Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | G6PD | P11413 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | FBP1 | P09467 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6260317 | 1.00 | TDP1 (0.59) | TDP1ALDH1A1KMT2AG6PDGAA | |
| SCHEMBL267779 | 1.00 | TDP1 (0.59) | TDP1ALDH1A1KMT2AG6PDGAA | |
| Hydrogen Sulfide SCHEMBL28326251 | 0.98 | TDP1 (0.58) | TDP1ALDH1A1KMT2AG6PDGAA | |
| Sulfuric Acid SCHEMBL27546343 | 0.89 | TDP1 (0.54) | TDP1ALDH1A1KMT2AG6PDGAA | |
| SCHEMBL5711161 | 0.81 | TDP1 (0.42) | TDP1ALDH1A1KMT2AGAAMAPT | |
| SCHEMBL15216491 | 0.80 | FBP1 (0.44) | TDP1ALDH1A1KMT2AGAAFBP1 | |
| SCHEMBL28552488 | 0.80 | FBP1 (0.44) | TDP1ALDH1A1KMT2AGAAFBP1 | |
| SCHEMBL4018127 | 0.79 | TDP1 (0.53) | TDP1ALDH1A1KMT2AG6PDGAA | |
| SCHEMBL29136456 | 0.79 | TDP1 (0.46) | TDP1ALDH1A1KMT2AG6PDFBP1 | |
| SCHEMBL4958358 | 0.78 | MAPT (0.48) | TDP1ALDH1A1KMT2AGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1626 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12364732-B2 | Systems and methods for treatment of hearing using dihexa | TRANSDERMAL BIOTECHNOLOGY, INC. (US) | 2025-07-22 | — | — | US | claimed |
| US-20240424050-A1 | SYSTEMS AND METHODS FOR TREATMENT OF HEARING USING DIHEXA | TRANSDERMAL BIOTECHNOLOGY, INC. (US) | 2024-12-26 | — | — | US | claimed |
| EP-4453001-A2 | DLL3 BINDING PEPTIDES AND USES THEREOF | AMGEN INC. (US) | 2024-10-30 | — | — | EP | claimed |
| CN-118852028-A | Nitrone pyrimidine ring compound and preparation method thereof | 南京工业大学 | 2024-10-29 | — | — | CN | claimed |
| CN-118791423-A | Polyhydroxy imine sugar compound with alpha-glucosidase inhibitory activity and preparation method thereof | 中国科学院成都生物研究所 | 2024-10-18 | — | — | CN | claimed |
| CN-118755113-A | Preparation process of low molecular weight fluoropolymer | 江苏天问新材料科技有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-118591771-A | Initiator composition, negative photosensitive resin composition, method for producing pattern cured film, and insulating film | 徐州博康信息化学品有限公司 | 2024-09-03 | — | — | CN | claimed |
| CN-118393812-B | Patterning composition, patterning film, patterning substrate, semiconductor device, and method of manufacturing the same | 珠海基石科技有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-118525249-A | Latent curing agent, low-temperature-cured photosensitive resin composition, method for producing pattern-cured film, and insulating film | 徐州博康信息化学品有限公司 | 2024-08-20 | — | — | CN | claimed |
| CN-118393812-A | Patterning composition, patterning film, patterning substrate, semiconductor device, and method of manufacturing the same | 珠海基石科技有限公司 | 2024-07-26 | — | — | CN | claimed |
| US-5622994-A | NITRONE DERIVATIVES | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1997-04-22 | — | — | US | claimed |
| US-5610699-A | Photoreceptor cleaning apparatus and method | XEROX CORPORATION (US) | 1997-03-11 | — | — | US | claimed |
| EP-0665003-B1 | The use of a spin acceptor in a cosmetic or dermatological composition | OREAL (FR) | 1996-08-28 | — | — | EP | claimed |
| US-5550272-A | Method for hydrosilating unsaturated monomers | GENERAL ELECTRIC COMPANY (US) | 1996-08-27 | — | — | US | claimed |
| EP-0665003-A1 | The use of a spin acceptor in a cosmetic on dermatological composition | L'OREAL (FR) | 1995-08-02 | — | — | EP | claimed |
| EP-0327263-B1 | Hair growth stimulation with nitroxide and other radicals | PROCTOR PETER H (US) | 1994-09-07 | — | — | EP | claimed |
| US-5106723-A | Contrast enhancement layer compositions, alkylnitrones, and use | MICROSI, INC. (US) | 1992-04-21 | — | — | US | claimed |
| US-5002993-A | Contrast enhancement layer compositions, alkylnitrones, and use | MICROSI, INC. (US) | 1991-03-26 | — | — | US | claimed |
| WO-1988005653-A1 | TOPICAL COMPOSITION FOR STIMULATING HAIR GROWTH WITH STABLE FREE RADICALS | PROCTOR PETER H (US) | 1988-08-11 | — | — | WO | claimed |
| US-3988229-A | Stabilized photopolymerizable polymeric compositions containing a photoinitiator and a nitrone derivative | EASTMAN KODAK COMPANY (US) | 1976-10-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12364732-B2 | Systems and methods for treatment of hearing using dihexa | PRPH, LTA, SPAST | TDP1 424/4885ALDH1A1 2405/4885KMT2A 2758/4885 |
| US-20240424050-A1 | SYSTEMS AND METHODS FOR TREATMENT OF HEARING USING DIHEXA | PRPH, LTA, SPAST | TDP1 424/4885ALDH1A1 2405/4885KMT2A 2758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.